Cipepofol

Cipepofol (Ciprofol), a novel 2,6-disubstituted phenol derivative, is a positive allosteric modulator and direct agonist of the GABAA receptor. Cipepofol can cause the central nerve inhibition and promote sleep based on the structural modification of Propofol. Cipepofol can activate the sirtuin1 (Sirt1)/Nrf2 pathway. Cipepofol protects the heart against Isoproterenol-induced myocardial infarction by reducing cardiac oxidative stress, inflammatory response and cardiomyocyte apoptosis


Cat. No.: EX-A14136	Purity: >98%

	Chemical structure of Cipepofol

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	495	In-stock
100mg	792	In-stock
250mg	1190	In-stock
500mg	1610	In-stock
1g	2180	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1637741-58-2
Purity	>98%
Formula	C14H20O
Mol Weight	204.308
Color	Colorless to light yellow
State	Liquid?Density?1.035
Solubility	DMSO : 100 mg/mL
Shelf Life	>3 years if stored properly
Storage	Pure form -20°C, 3 years , 4°C, 2 years; In solvent -20°C, 1 month.
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Ming Lu, et al. Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia? Biomed Res Int. 2023 Jan 19:2023:7443226. [2]. Yunzhao Yang, et al. Ciprofol attenuates the isoproterenol-induced oxidative damage, inflammatory response and cardiomyocyte apoptosis. Front Pharmacol. 2022 Nov 22:13:1037151.
CoA	CoA of Cipepofol

Smiles:	C[C@H](C1CC1)C2=CC=CC(=C2O)C(C)C


		Search